Current understanding of fungal microflora in inflammatory bowel disease pathogenesis

Authors

  • David Underhill PhD,

    1. Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California
    2. Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California
    Search for more papers by this author
  • Jonathan Braun MD, PhD

    Corresponding author
    1. Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California
    • Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095
    Search for more papers by this author

Errata

This article is corrected by:

  1. Errata: Erratum: Current understanding of fungal microflora in inflammatory bowel disease pathogenesis Volume 18, Issue 3, 1449, Article first published online: 13 February 2012

Abstract

Inflammatory bowel diseases are a current and growing public health problem, with a prevalence that appears to be increasing in most countries and cultures. While most research into the triggering phenomenon has focused on the interaction between commensal bacteria and inflammatory bowel disease, enteric fungi may also be important in determining disease susceptibility. Herein we review what is known about enteric fungi and the mechanisms by which they and their dysregulation might be involved in triggering inflammatory diseases of the bowel.

(Inflamm Bowel Dis 2008)

Ancillary